Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAT: Azithromycin in Bronchiectasis
NCT00415350Phase 3Completed
- Start
- Apr 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bronchiectasis comparing Azithromycin with Placebo (2 arms). Primary endpoints: Number of infective exacerbations at 1 year, Forced Expiratory Volume in 1 second at 1 year and 1 more. Started Apr 2008; status: completed.
02
Drugs
azithromycin
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT00415350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00415350.